Valuation: Sysmex Corporation

Market Cap 986B 6.07B 5.32B 4.92B 4.52B 8.54B 585B 8.68B 58.3B 22.98B 287B 22.79B 22.29B P/E 2027 *
24.3x
P/E 2028 * 20.1x
Enterprise Value 991B 6.1B 5.35B 4.94B 4.55B 8.59B 588B 8.72B 58.61B 23.1B 288B 22.91B 22.41B EV / Sales 2027 *
1.85x
EV / Sales 2028 * 1.75x
Free-Float
72.3%
Yield 2027 *
2.3%
Yield 2028 * 2.42%
1 day+4.96%
1 week+6.34%
Current month+10.71%
1 month+19.35%
3 months+13.29%
6 months+3.14%
Current year+5.54%
1 week 1,529
Extreme 1529
1,631.5
1 month 1,358.5
Extreme 1358.5
1,631.5
Current year 1,246
Extreme 1246
1,631.5
1 year 1,246
Extreme 1246
2,563.5
3 years 1,246
Extreme 1246
3,243
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 67 01/06/2014
Director/Board Member 68 01/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
+4.96%+6.34%-34.24%-48.97% 6.07B
+0.97%+8.23%-17.80%-5.24% 175B
+0.11%-0.69%-7.05%-3.29% 106B
-1.27%+0.18%+3.80%+58.38% 59.91B
+0.66%+0.96%+37.64%+54.22% 51.95B
-2.33%+1.67%-13.63%-39.40% 43.58B
-2.29%-5.26% - - 33.65B
-1.25%+0.97%-9.77%-43.36% 29.58B
-1.65%-0.39%+67.06%-8.64% 25.31B
-1.55%-0.71%-4.93%-5.70% 21.23B
Average -0.36%+2.06%+2.34%-4.66% 55.31B
Weighted average by Cap. -0.22%+2.79%-2.29%+2.71%

Financials

2027 *2028 *
Net sales 535B 3.29B 2.88B 2.67B 2.45B 4.63B 317B 4.71B 31.63B 12.47B 155B 12.36B 12.09B 566B 3.48B 3.05B 2.82B 2.59B 4.9B 336B 4.98B 33.46B 13.19B 164B 13.08B 12.79B
Net income 41.09B 253M 222M 205M 188M 356M 24.38B 362M 2.43B 957M 11.94B 949M 929M 49.61B 305M 268M 247M 227M 430M 29.44B 437M 2.93B 1.16B 14.42B 1.15B 1.12B
Net Debt 5.21B 32.07M 28.11M 26M 23.91M 45.15M 3.09B 45.88M 308M 121M 1.51B 120M 118M 3.7B 22.74M 19.93M 18.43M 16.95M 32.01M 2.19B 32.53M 219M 86.14M 1.07B 85.42M 83.56M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
17/07/26 JP¥1,628.00 +4.96% 5,271,100
16/07/26 JP¥1,551.00 +0.65% 1,966,900
15/07/26 JP¥1,541.00 -1.28% 1,716,400
14/07/26 JP¥1,561.00 +0.61% 1,993,600
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,628.00JPY
Average target price
1,719.33JPY
Spread / Average Target
+5.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock